🇺🇸 FDA
Patent

US 8324236

Crystalline forms of a 3-carboxypropyl-aminotetralin compound

granted A61PA61P1/00A61P1/14

Quick answer

US patent 8324236 (Crystalline forms of a 3-carboxypropyl-aminotetralin compound) held by Theravance, Inc. expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P1/00, A61P1/14, A61P25/04, A61P29/00